ID   PDGFD_RAT               Reviewed;         370 AA.
AC   Q9EQT1;
DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   24-JUL-2024, entry version 124.
DE   RecName: Full=Platelet-derived growth factor D;
DE            Short=PDGF-D;
DE   AltName: Full=Iris-expressed growth factor;
DE   AltName: Full=Spinal cord-derived growth factor B;
DE            Short=SCDGF-B;
DE   Contains:
DE     RecName: Full=Platelet-derived growth factor D, latent form;
DE              Short=PDGFD latent form;
DE   Contains:
DE     RecName: Full=Platelet-derived growth factor D, receptor-binding form;
DE              Short=PDGFD receptor-binding form;
DE   Flags: Precursor;
GN   Name=Pdgfd; Synonyms=Iegf, Scdgfb;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=11162582; DOI=10.1006/bbrc.2000.4187;
RA   Hamada T., Ui-Tei K., Imaki J., Miyata Y.;
RT   "Molecular cloning of SCDGF-B, a novel growth factor homologous to
RT   SCDGF/PDGF-C/fallotein.";
RL   Biochem. Biophys. Res. Commun. 280:733-737(2001).
RN   [2]
RP   IDENTIFICATION OF ISOFORM 2, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=11850188; DOI=10.1016/s0925-4773(01)00625-6;
RA   Hamada T., Ui-Tei K., Imaki J., Takahashi F., Onodera H., Mishima T.,
RA   Miyata Y.;
RT   "The expression of SCDGF/PDGF-C/fallotein and SCDGF-B/PDGF-D in the rat
RT   central nervous system.";
RL   Mech. Dev. 112:161-164(2002).
RN   [3]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=12937299; DOI=10.1097/01.asn.0000083393.00959.02;
RA   Ostendorf T., van Roeyen C.R.C., Peterson J.D., Kunter U., Eitner F.,
RA   Hamad A.J., Chan G., Jia X.-C., Macaluso J., Gazit-Bornstein G., Keyt B.A.,
RA   Lichenstein H.S., LaRochelle W.J., Floege J.;
RT   "A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel
RT   mediator of mesangioproliferative glomerulonephritis.";
RL   J. Am. Soc. Nephrol. 14:2237-2247(2003).
RN   [4]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15611105; DOI=10.1074/jbc.m413570200;
RA   Ray S., Gao C., Wyatt K., Fariss R.N., Bundek A., Zelenka P., Wistow G.;
RT   "Platelet-derived growth factor D, tissue-specific expression in the eye,
RT   and a key role in control of lens epithelial cell proliferation.";
RL   J. Biol. Chem. 280:8494-8502(2005).
CC   -!- FUNCTION: Growth factor that plays an essential role in the regulation
CC       of embryonic development, cell proliferation, cell migration, survival
CC       and chemotaxis. Potent mitogen for cells of mesenchymal origin. Plays
CC       an important role in wound healing. Induces macrophage recruitment,
CC       increased interstitial pressure, and blood vessel maturation during
CC       angiogenesis (By similarity). May play an important role in control of
CC       lens epithelial cell proliferation. Can initiate events that lead to a
CC       mesangial proliferative glomerulonephritis, including influx of
CC       monocytes and macrophages and production of extracellular matrix.
CC       {ECO:0000250, ECO:0000269|PubMed:12937299,
CC       ECO:0000269|PubMed:15611105}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Interacts with PDGFRB homodimers,
CC       and with heterodimers formed by PDGFRA and PDGFRB (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}. Note=Released by
CC       platelets upon wounding. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9EQT1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9EQT1-2; Sequence=VSP_020619;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed at high levels in the
CC       kidney, adrenal glands, eye and CNS. In the kidney the localization is
CC       confined to arterial and arteriolar vascular smooth muscle cells and is
CC       also detected at low levels in the glomeruli In the eye in the anterior
CC       segment it is localized to the iris and ciliary body. In the retina
CC       localizes intensely to the outer plexiform layer, which contains
CC       photoreceptor axons and the synaptic layer between photoreceptors and
CC       second order neurons. In the spinal cord, prominently expressed in the
CC       motorneurons. {ECO:0000269|PubMed:11850188,
CC       ECO:0000269|PubMed:12937299, ECO:0000269|PubMed:15611105}.
CC   -!- DEVELOPMENTAL STAGE: Not detected in the spinal cord at 21 dpc.
CC       Expressed weakly at postnatal day 1 (P1) and a strong expression seen
CC       at P21 and this continues into adulthood.
CC       {ECO:0000269|PubMed:11850188}.
CC   -!- PTM: Activated by proteolytic cleavage. Proteolytic removal of the N-
CC       terminal CUB domain releasing the core domain is necessary for
CC       unmasking the receptor-binding epitopes of the core domain. Cleavage
CC       after Arg-247 or Arg-249 by urokinase plasminogen activator gives rise
CC       to the active form (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the PDGF/VEGF growth factor family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB052170; BAB18920.1; -; mRNA.
DR   PIR; JC7592; JC7592.
DR   RefSeq; NP_076452.1; NM_023962.2. [Q9EQT1-1]
DR   AlphaFoldDB; Q9EQT1; -.
DR   SMR; Q9EQT1; -.
DR   STRING; 10116.ENSRNOP00000068187; -.
DR   GlyCosmos; Q9EQT1; 1 site, No reported glycans.
DR   GlyGen; Q9EQT1; 1 site.
DR   PhosphoSitePlus; Q9EQT1; -.
DR   PaxDb; 10116-ENSRNOP00000068187; -.
DR   Ensembl; ENSRNOT00000076529.3; ENSRNOP00000068187.2; ENSRNOG00000029148.7. [Q9EQT1-2]
DR   Ensembl; ENSRNOT00055009557; ENSRNOP00055007370; ENSRNOG00055005903. [Q9EQT1-1]
DR   Ensembl; ENSRNOT00060026736; ENSRNOP00060021411; ENSRNOG00060015604. [Q9EQT1-1]
DR   Ensembl; ENSRNOT00065003672; ENSRNOP00065002555; ENSRNOG00065002703. [Q9EQT1-1]
DR   GeneID; 66018; -.
DR   KEGG; rno:66018; -.
DR   UCSC; RGD:621880; rat. [Q9EQT1-1]
DR   AGR; RGD:621880; -.
DR   CTD; 80310; -.
DR   RGD; 621880; Pdgfd.
DR   VEuPathDB; HostDB:ENSRNOG00000029148; -.
DR   eggNOG; ENOG502QPQY; Eukaryota.
DR   GeneTree; ENSGT00940000159575; -.
DR   HOGENOM; CLU_037859_1_0_1; -.
DR   InParanoid; Q9EQT1; -.
DR   OMA; HHETCEC; -.
DR   OrthoDB; 3908391at2759; -.
DR   PhylomeDB; Q9EQT1; -.
DR   Reactome; R-RNO-186797; Signaling by PDGF.
DR   PRO; PR:Q9EQT1; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000029148; Expressed in stomach and 17 other cell types or tissues.
DR   ExpressionAtlas; Q9EQT1; baseline and differential.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0016020; C:membrane; IEA:InterPro.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0005161; F:platelet-derived growth factor receptor binding; IBA:GO_Central.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISO:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IEP:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IMP:RGD.
DR   GO; GO:0048008; P:platelet-derived growth factor receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
DR   GO; GO:0030335; P:positive regulation of cell migration; IBA:GO_Central.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IBA:GO_Central.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IBA:GO_Central.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IDA:RGD.
DR   GO; GO:0072126; P:positive regulation of glomerular mesangial cell proliferation; IMP:RGD.
DR   GO; GO:2000439; P:positive regulation of monocyte extravasation; IMP:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IBA:GO_Central.
DR   GO; GO:0031954; P:positive regulation of protein autophosphorylation; IBA:GO_Central.
DR   GO; GO:0071673; P:positive regulation of smooth muscle cell chemotaxis; IMP:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IDA:RGD.
DR   GO; GO:0050730; P:regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   CDD; cd00041; CUB; 1.
DR   CDD; cd00135; PDGF; 1.
DR   Gene3D; 2.10.90.10; Cystine-knot cytokines; 1.
DR   Gene3D; 2.60.120.290; Spermadhesin, CUB domain; 1.
DR   InterPro; IPR000859; CUB_dom.
DR   InterPro; IPR029034; Cystine-knot_cytokine.
DR   InterPro; IPR000072; PDGF/VEGF_dom.
DR   InterPro; IPR035914; Sperma_CUB_dom_sf.
DR   PANTHER; PTHR11633; PLATELET-DERIVED GROWTH FACTOR; 1.
DR   PANTHER; PTHR11633:SF4; PLATELET-DERIVED GROWTH FACTOR D; 1.
DR   Pfam; PF00431; CUB; 1.
DR   Pfam; PF00341; PDGF; 1.
DR   SMART; SM00042; CUB; 1.
DR   SMART; SM00141; PDGF; 1.
DR   SUPFAM; SSF57501; Cystine-knot cytokines; 1.
DR   SUPFAM; SSF49854; Spermadhesin, CUB domain; 1.
DR   PROSITE; PS01180; CUB; 1.
DR   PROSITE; PS50278; PDGF_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cleavage on pair of basic residues;
KW   Developmental protein; Disulfide bond; Glycoprotein; Growth factor;
KW   Mitogen; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..370
FT                   /note="Platelet-derived growth factor D, latent form"
FT                   /id="PRO_0000250196"
FT   CHAIN           250..370
FT                   /note="Platelet-derived growth factor D, receptor-binding
FT                   form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000250197"
FT   DOMAIN          52..170
FT                   /note="CUB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   SITE            247..248
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000255"
FT   SITE            249..250
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        276
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        109..131
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DISULFID        296
FT                   /note="Interchain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DISULFID        302..360
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DISULFID        306..362
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   VAR_SEQ         42..47
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_020619"
SQ   SEQUENCE   370 AA;  42809 MW;  7BE8A251F679BF73 CRC64;
     MHRLILVSIL VCANFCCYRD TFATPQSASI KALRNANLRR DESNHLTDLY RRDENIRVTG
     TGHVQSPRFP NSYPRNLLLT WRLHSQEKTR IQLAFDHQFG LEEAENDICR YDFVEVEDVS
     ESSTVVRGRW CGHKEIPPRI TSRTNQIKIT FQSDDYFVAK PGFKIYYSFV EDFQPEAASE
     INWESVTSSF SGVSYHSPSV MDSTLTADAL DKAIAEFDTV EDLLKYFNPA SWQDDLENLY
     MDTPRYRGRS YHERKSKVDL DRLNDDVKRY SCTPRNHSVN LREELKLTNA VFFPRCLLVQ
     RCGGNCGCGT LNWKSCTCSS GKTVKKYHEV LKFEPGHFKR RGKAKNMALV DIQLDHHERC
     DCICSSRPPR
//
